Tactiva Therapeutics Email Format
Biotechnology ResearchNew York, United States2-10 Employees
Tactiva Therapeutics is a biotechnology research company focused on immuno-oncology, developing cancer therapies that utilize a dual T cell receptor approach. The aim of its work is to enable adoptive cellular therapy with the potential to address a broad range of cancers, positioning the company within the emerging area of next-generation cancer immunotherapies. Based in Buffalo, New York, the firm operates with a small team and is at development-stage, pursuing clinical and preclinical exploration of its therapeutic strategies. A notable recent development is the company’s advancement in its autologous cellular immunotherapy program, as reported in 2017.